Tag Archives: Amgen Inc.

Mizuho Securities Reaffirms Their Hold Rating on Amgen Inc (AMGN)

In a report released today, Salim Syed from Mizuho Securities maintained a Hold rating on Amgen Inc (AMGN – Research Report), with a price target of $212.00. The company’s shares closed last Monday at $205.01, close to its 52-week high

Mizuho Securities Sticks to Their Hold Rating for Amgen Inc (AMGN)

In a report released today, Salim Syed from Mizuho Securities maintained a Hold rating on Amgen Inc (AMGN – Research Report), with a price target of $212.00. The company’s shares closed last Monday at $194.94. According to TipRanks.com, Syed is

Amgen Inc (NASDAQ: AMGN) Executives are Making Moves with Their Shares

Yesterday, the SVP & CCO of Amgen Inc (AMGN – Research Report), Cynthia Patton, sold shares of AMGN for $1.79M. See today’s analyst top recommended stocks >> The company has a one-year high of $211.90 and a one-year low of

Amgen Inc (AMGN) Gets a Hold Rating from J.P. Morgan

In a report issued on August 30, Cory Kasimov from J.P. Morgan maintained a Hold rating on Amgen Inc (AMGN – Research Report). The company’s shares closed last Monday at $208.62, close to its 52-week high of $211.90. According to

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen Inc (NASDAQ: AMGN) and Zogenix (NASDAQ: ZGNX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen Inc (AMGN – Research Report) and Zogenix (ZGNX – Research Report). Amgen Inc (AMGN) William Blair analyst Matt Phipps maintained a Hold rating on

J.P. Morgan Sticks to Their Hold Rating for Amgen Inc (AMGN)

J.P. Morgan analyst Cory Kasimov maintained a Hold rating on Amgen Inc (AMGN – Research Report) yesterday. The company’s shares closed last Monday at $205.41, close to its 52-week high of $211.90. According to TipRanks.com, Kasimov is a 3-star analyst